| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Apollo Endosurgery, Inc. | Director | Common Stock | 0 | $6.46 | 04 Apr 2023 | by Trust | |
| Apollo Endosurgery, Inc. | Director | Common Stock | 0 | $6.46 | 04 Apr 2023 | Direct | |
| Apollo Endosurgery, Inc. | Director | Stock Option (Right to Buy) | 0 | $8.69 | 04 Apr 2023 | Direct | |
| REATA PHARMACEUTICALS INC | Director | Class A common stock | 0 | $172.03 | 26 Sep 2023 | Direct | |
| REATA PHARMACEUTICALS INC | Director | Class B common stock | 0 | $172.03 | 28 Jul 2023 | Direct | |
| REATA PHARMACEUTICALS INC | Director | Stock Option (right to buy) | 0 | $73.68 | 26 Sep 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RETA | REATA PHARMACEUTICALS INC | 26 Sep 2023 | 12 | $0 | 4 | 26 Sep 2023 | Director |
| RETA | REATA PHARMACEUTICALS INC | 28 Jul 2023 | 5 | -$690K | 4 | 01 Aug 2023 | Director |
| RETA | REATA PHARMACEUTICALS INC | 07 Jun 2023 | 4 | $177K | 4 | 09 Jun 2023 | Director |
| APEN | Apollo Endosurgery, Inc. | 04 Apr 2023 | 9 | $0 | 4 | 04 Apr 2023 | Director |
| APEN | Apollo Endosurgery, Inc. | 14 Jun 2022 | 2 | $0 | 4 | 16 Jun 2022 | Director |
| RETA | REATA PHARMACEUTICALS INC | 08 Jun 2022 | 4 | $155K | 4 | 09 Jun 2022 | Director |
| RETA | REATA PHARMACEUTICALS INC | 03 Jan 2022 | 2 | $3.21K | 4 | 05 Jan 2022 | Director |
| APEN | Apollo Endosurgery, Inc. | 17 Jun 2021 | 2 | $46.7K | 4 | 21 Jun 2021 | Director |
| RETA | REATA PHARMACEUTICALS INC | 10 Jun 2021 | 1 | $0 | 4 | 14 Jun 2021 | Director |